View Older Stories View More Recent Stories

Mar 30, 2021 04:02PM CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update
Mar 25, 2021 07:00AM Passage Bio to Participate in Upcoming April Investor Conferences
Mar 25, 2021 07:00AM Passage Bio to Participate in Upcoming April Investor Conferences
Mar 25, 2021 06:02AM Form S-1/A CHARDAN NEXTECH ACQUISIT
Mar 24, 2021 06:44AM Modiv Acquisition Corp. (“MAC SPAC”) Announces Filing of Registration Statement
Mar 23, 2021 04:22PM Solid Biosciences Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
Mar 23, 2021 09:03AM Renovacor to Come Public Through Merger with SPAC Chardan Healthcare Acquisition 2 Corp. (CHAQ)
Mar 23, 2021 08:14AM Form 8-K Chardan Healthcare Acqui For: Mar 22
Mar 23, 2021 08:12AM Form DEFA14A Chardan Healthcare Acqui
Mar 23, 2021 08:00AM Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.
Mar 22, 2021 04:19PM Chardan Expands Research Team, Welcomes Managing Director and Director of Research
Mar 19, 2021 06:05AM Form S-1/A CHARDAN NEXTECH ACQUISIT
Mar 19, 2021 06:02AM Solid Biosciences (SLDB) Prices 21.74M Share Common Offering at $5.75/Sh
Mar 18, 2021 09:14PM Solid Biosciences Announces Pricing of Public Offering of Common Stock
Mar 17, 2021 05:10PM Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation
Mar 17, 2021 04:20PM Solid Biosciences (SLDB) to Offer $85M in Common Stock
Mar 17, 2021 04:20PM Solid Biosciences Announces Proposed Public Offering of Common Stock
Mar 17, 2021 09:59AM Forte Biosciences Inc. (FBRX) PT Lowered to $105 at Chardan Capital Markets
Mar 17, 2021 09:23AM 4D Pharma Announces Private Placement
Mar 16, 2021 11:47AM Solid Biosciences (SLDB) PT Raised to $20 at Chardan Capital Markets
Mar 16, 2021 10:36AM ContraFect Corp. (CFRX) PT Raised to $17.50 at Chardan Capital Markets
Mar 11, 2021 04:10PM Homology Medicines Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
Mar 10, 2021 09:01AM Outcome Capital Expands Life Science Practice with Addition of Digital Health Industry Veterans
Mar 10, 2021 06:07AM Form S-1/A CHARDAN NEXTECH ACQUISIT
Mar 10, 2021 06:04AM Form S-1/A Chardan NexTech Acquisit
Mar 8, 2021 05:27PM Form S-1 Chardan NexTech Acquisit
Mar 8, 2021 06:40AM Passage Bio Inc. (PASG) PT Raised to $45 at Chardan Capital Markets
Mar 7, 2021 05:46AM 5 Penny Stocks To Watch This Week As Biotech Takes Spotlight
Mar 5, 2021 05:27PM Form S-1 CHARDAN NEXTECH ACQUISIT
Mar 5, 2021 04:55PM Quantum FinTech Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing March 10, 2021
Mar 5, 2021 04:55PM Quantum FinTech Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing March 10, 2021
Mar 5, 2021 08:15AM Chardan Capital Markets Upgrades Seres Therapeutics (MCRB) to Buy
Mar 4, 2021 05:13PM Form 10-K Chardan Healthcare Acqui For: Dec 31
Mar 4, 2021 08:52AM Taysha Gene Therapies (TSHA) PT Raised to $60 at Chardan Capital Markets
Mar 3, 2021 08:00AM Senda Biosciences to virtually present at the Chardan 3rd Annual Microbiome Medicines Summit
Mar 3, 2021 07:00AM 4D Pharma to Present at Upcoming Investor Conferences in March
Mar 2, 2021 07:00AM Vedanta Biosciences to Present at Upcoming Investor Conferences
Mar 1, 2021 06:26PM Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
Mar 1, 2021 04:43PM Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
Mar 1, 2021 09:00AM Enterin to Present at Chardan's Virtual 3rd Annual Microbiome Medicines Summit
Mar 1, 2021 07:30AM Kaleido Biosciences to Present at Chardan’s 3rd Annual Microbiome Medicines Summit
Mar 1, 2021 07:30AM Kaleido Biosciences to Present at Chardan’s 3rd Annual Microbiome Medicines Summit
Mar 1, 2021 07:05AM uniQure Announces 2020 Financial Results and Highlights Recent Company Progress
Mar 1, 2021 07:00AM BiomX to Present at Upcoming March Investor Conferences
Mar 1, 2021 06:30AM Emergent BioSolutions to Participate in Investor Conferences
Mar 1, 2021 06:30AM Emergent BioSolutions to Participate in Investor Conferences
Feb 26, 2021 08:00AM Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
Feb 24, 2021 07:12AM Chardan Capital Markets Upgrades Emergent BioSolutions (EBS) to Buy on Sell-Off
Feb 23, 2021 04:01PM Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th
Feb 22, 2021 08:08AM Lottery.com Enters into Definitive Agreement with Trident Acquisitions Corp. (TDAC) to Become Publicly Traded
View More Recent Stories View Older Stories